Moscow 2013
The Association of Clinical Trials Organizations (ACTO) presented newsletter No. 7 with results from the first half of 2013 detailing the state of clinical trials in Russia.
During the first half of 2013, the Russian Ministry of Health issued 404 approvals for conducting clinical trials, down 10% from the same time last year. The number of international trials is also down 14.1% from last year, as is the number of bioequivalence studies, which is down 20.7%.
You can read the full report, including analysis of these numbers and thoughts on possible causes, (PDF) here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
2 Commerce Drive
Cranbury, NJ 08512